SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-96-000013
Filing Date
1996-08-14
Accepted
1996-08-14 00:00:00
Documents
6
Period of Report
1996-06-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 LIGAND PHARMACEUTICALS, INC. -- FORM 10-Q 10-Q 42727
2 EXHIBIT 10.149 EX-10.149 36453
3 EXHIBIT 10.150 EX-10.150 17547
4 EXHIBIT 10.151 EX-10.151 41133
5 EXHIBIT 10.152 EX-10.152 2265
6 FINANCIAL DATA SCHEDULE EX-27 2498
  Complete submission text file 0000886163-96-000013.txt   144562
Mailing Address 9393 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DR STE 100 SAN DIEGO CA 92121 6195353900
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 96613087
SIC: 2834 Pharmaceutical Preparations